These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32948788)

  • 81. AAV-Mediated CRISPR/Cas Gene Editing of Retinal Cells In Vivo.
    Hung SS; Chrysostomou V; Li F; Lim JK; Wang JH; Powell JE; Tu L; Daniszewski M; Lo C; Wong RC; Crowston JG; Pébay A; King AE; Bui BV; Liu GS; Hewitt AW
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3470-6. PubMed ID: 27367513
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
    Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
    Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Herpes simplex virus type 1/adeno-associated virus rep(+) hybrid amplicon vector improves the stability of transgene expression in human cells by site-specific integration.
    Wang Y; Camp SM; Niwano M; Shen X; Bakowska JC; Breakefield XO; Allen PD
    J Virol; 2002 Jul; 76(14):7150-62. PubMed ID: 12072515
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effective control of large deletions after double-strand breaks by homology-directed repair and dsODN insertion.
    Wen W; Quan ZJ; Li SA; Yang ZX; Fu YW; Zhang F; Li GH; Zhao M; Yin MD; Xu J; Zhang JP; Cheng T; Zhang XB
    Genome Biol; 2021 Aug; 22(1):236. PubMed ID: 34416913
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Generation of functional murine cardiac myocytes from induced pluripotent stem cells.
    Mauritz C; Schwanke K; Reppel M; Neef S; Katsirntaki K; Maier LS; Nguemo F; Menke S; Haustein M; Hescheler J; Hasenfuss G; Martin U
    Circulation; 2008 Jul; 118(5):507-17. PubMed ID: 18625890
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Utility of Self-Destructing CRISPR/Cas Constructs for Targeted Gene Editing in the Retina.
    Li F; Hung SSC; Mohd Khalid MKN; Wang JH; Chrysostomou V; Wong VHY; Singh V; Wing K; Tu L; Bender JA; Pébay A; King AE; Cook AL; Wong RCB; Bui BV; Hewitt AW; Liu GS
    Hum Gene Ther; 2019 Nov; 30(11):1349-1360. PubMed ID: 31373227
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Heme Oxygenase-1/Carbon Monoxide System and Embryonic Stem Cell Differentiation and Maturation into Cardiomyocytes.
    Suliman HB; Zobi F; Piantadosi CA
    Antioxid Redox Signal; 2016 Mar; 24(7):345-60. PubMed ID: 26725491
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A Compact, High-Accuracy Cas9 with a Dinucleotide PAM for In Vivo Genome Editing.
    Edraki A; Mir A; Ibraheim R; Gainetdinov I; Yoon Y; Song CQ; Cao Y; Gallant J; Xue W; Rivera-Pérez JA; Sontheimer EJ
    Mol Cell; 2019 Feb; 73(4):714-726.e4. PubMed ID: 30581144
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci.
    Padmaswari MH; Bulliard G; Agrawal S; Jia MS; Khadgi S; Murach KA; Nelson CE
    Mol Ther Nucleic Acids; 2024 Dec; 35(4):102320. PubMed ID: 39398225
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci.
    Padmaswari MH; Bulliard GN; Agrawal S; Jia MS; Nelson CE
    bioRxiv; 2024 Mar; ():. PubMed ID: 38562818
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Pulmonary vein isolation alone vs. more extensive ablation with defragmentation and linear ablation of persistent atrial fibrillation: the EARNEST-PVI trial.
    Inoue K; Hikoso S; Masuda M; Furukawa Y; Hirata A; Egami Y; Watanabe T; Minamiguchi H; Miyoshi M; Tanaka N; Oka T; Okada M; Kanda T; Matsuda Y; Kawasaki M; Hayashi K; Kitamura T; Dohi T; Sunaga A; Mizuno H; Nakatani D; Sakata Y;
    Europace; 2021 Apr; 23(4):565-574. PubMed ID: 33200213
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Study protocol for the PURSUIT-HFpEF study: a Prospective, Multicenter, Observational Study of Patients with Heart Failure with Preserved Ejection Fraction.
    Suna S; Hikoso S; Yamada T; Uematsu M; Yasumura Y; Nakagawa A; Takeda T; Kojima T; Kida H; Oeun B; Sunaga A; Kitamura T; Dohi T; Okada K; Mizuno H; Nakatani D; Iso H; Matsumura Y; Sakata Y;
    BMJ Open; 2020 Oct; 10(10):e038294. PubMed ID: 33060085
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Phenotypic recapitulation and correction of desmoglein-2-deficient cardiomyopathy using human-induced pluripotent stem cell-derived cardiomyocytes.
    Shiba M; Higo S; Kondo T; Li J; Liu L; Ikeda Y; Kohama Y; Kameda S; Tabata T; Inoue H; Nakamura S; Takeda M; Ito E; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
    Hum Mol Genet; 2021 Jul; 30(15):1384-1397. PubMed ID: 33949662
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Decreased YAP activity reduces proliferative ability in human induced pluripotent stem cell of duchenne muscular dystrophy derived cardiomyocytes.
    Yasutake H; Lee JK; Hashimoto A; Masuyama K; Li J; Kuramoto Y; Higo S; Hikoso S; Hidaka K; Naito AT; Miyagawa S; Sawa Y; Komuro I; Sakata Y
    Sci Rep; 2021 May; 11(1):10351. PubMed ID: 33990626
    [TBL] [Abstract][Full Text] [Related]  

  • 95. High density lipoprotein cholesterol / C reactive protein ratio in heart failure with preserved ejection fraction.
    Yano M; Nishino M; Ukita K; Kawamura A; Nakamura H; Matsuhiro Y; Yasumoto K; Tsuda M; Okamoto N; Tanaka A; Matsunaga-Lee Y; Egami Y; Shutta R; Tanouchi J; Yamada T; Yasumura Y; Tamaki S; Hayashi T; Nakagawa A; Nakagawa Y; Suna S; Nakatani D; Hikoso S; Sakata Y;
    ESC Heart Fail; 2021 Aug; 8(4):2791-2801. PubMed ID: 33934563
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice.
    Dalwadi DA; Torrens L; Abril-Fornaguera J; Pinyol R; Willoughby C; Posey J; Llovet JM; Lanciault C; Russell DW; Grompe M; Naugler WE
    Mol Ther; 2021 Feb; 29(2):680-690. PubMed ID: 33554867
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Enhanced Efficacy and Increased Long-Term Toxicity of CNS-Directed, AAV-Based Combination Therapy for Krabbe Disease.
    Li Y; Miller CA; Shea LK; Jiang X; Guzman MA; Chandler RJ; Ramakrishnan SM; Smith SN; Venditti CP; Vogler CA; Ory DS; Ley TJ; Sands MS
    Mol Ther; 2021 Feb; 29(2):691-701. PubMed ID: 33388420
    [TBL] [Abstract][Full Text] [Related]  

  • 98. hiPSC-Derived Cardiac Tissue for Disease Modeling and Drug Discovery.
    Li J; Hua Y; Miyagawa S; Zhang J; Li L; Liu L; Sawa Y
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255277
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Evaluating the Genomic Parameters Governing rAAV-Mediated Homologous Recombination.
    Spector LP; Tiffany M; Ferraro NM; Abell NS; Montgomery SB; Kay MA
    Mol Ther; 2021 Mar; 29(3):1028-1046. PubMed ID: 33248247
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells.
    Nguyen GN; Everett JK; Kafle S; Roche AM; Raymond HE; Leiby J; Wood C; Assenmacher CA; Merricks EP; Long CT; Kazazian HH; Nichols TC; Bushman FD; Sabatino DE
    Nat Biotechnol; 2021 Jan; 39(1):47-55. PubMed ID: 33199875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.